Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 3.8B | 3.6B | 3.6B | 3.5B |
| Cost of revenue | 1.2B | 1.1B | 1.1B | 1.1B |
| Gross profit | 2.6B | 2.5B | 2.5B | 2.5B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 764M | 919M | 808M | 734M |
| Other operating expenses | — | — | — | — |
| Operating income | 1.6B | 1.3B | 1.4B | 1.4B |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 78M | 70M | 72M | 77M |
| Other income expense | 7M | 65M | 30M | 16M |
| Pretax income | 1.5B | 1.3B | 1.4B | 1.4B |
| Tax provision | 325M | 287M | 313M | 293M |
| Net income | 1.2B | 967M | 1.0B | 1.1B |
| Basic EPS | — | — | — | — |
| Diluted EPS | — | — | — | — |
| Basic average shares | — | — | — | — |
| Diluted average shares | — | — | — | — |
| EBITDA | 1.9B | 1.6B | 1.7B | 1.8B |
| Net income from continuing op. | 1.2B | 967M | 1.0B | 1.1B |
| Minority interests | -81M | -87M | -76M | -74M |
| Preferred stock dividends | — | — | — | — |